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the quantitative analysis were narratively summarised. Risk of bias assessment was conducted using
the revised tool for the Quality Assessment on Diagnostic Accuracy Studies. RESULTS The systematic
literature search retrieved 617 articles. Seven articles were included in the qualitative analysis and the
meta-analysis. Pooled proportions revealed 37% of patients with ED after suffering any form of PRF
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Strengths and limitations of this study
 ► Despite the strict definition of pelvic ring fracture 
(PRF) and erectile dysfunction (ED), there is still 
an inevitable variability due to the heterogeneous 
methodological nature of available studies and study 
populations from different centres worldwide.
 ► Resulting from the lack of standardisation, a broad 
variety of classifications for PRF and different defi-
nitions and questionnaires for the evaluation of ED 
were used.
 ► Included studies provide a certain risk of bias.
 ► The included results were consistent across studies.
AbStrACt
Objective To investigate the rate of erectile dysfunction 
(ED) after pelvic ring fracture (PRF).
Design Systematic review and meta- analysis.
Methods A systematic literature search of the Cochrane, 
EMBASE, MEDLINE, Scopus and Web of Science Library 
databases was conducted in January 2020. Included 
were original studies performed on humans assessing 
ED after PRF according to the 5- item International Index 
of Erectile Function (IIEF-5) questionnaire and fracture 
classification following Young and Burgess, Tile or 
Arbeitsgemeinschaft für Osteosynthesefragen/Orthopedic 
Trauma Association. Furthermore, interventional cohort 
studies assessing the effect of penile rehabilitation 
therapy with phosphodiesterase-5- inhibitors (PDE-5- I) 
on IIEF-5 scores compared before and after treatment 
were included. Results were presented as forest plots 
of proportions of patients with ED after PRF or mean 
changes on IIEF-5 questionnaires before and after penile 
rehabilitation. Studies not included in the quantitative 
analysis were narratively summarised. Risk of bias 
assessment was conducted using the revised tool for the 
Quality Assessment on Diagnostic Accuracy Studies.
results The systematic literature search retrieved 617 
articles. Seven articles were included in the qualitative 
analysis and the meta- analysis. Pooled proportions 
revealed 37% of patients with ED after suffering any form 
of PRF (result on probability scale pr=0.37, 95% CI: 0.26 
to 0.50). Patients after 3 months of penile rehabilitation 
therapy reported a higher IIEF-5 score than before (change 
score=6.5 points, 95% CI: 2.54 to 10.46, p value=0.0013).
Conclusion Despite some heterogeneity and limited 
high- quality research, this study concludes that patients 
suffering from any type of PRF have an increased risk of 
developing ED. Oral intake of PDE-5- I for the purpose of 
penile rehabilitation therapy increases IIEF-5 scores and 
may relevantly influence quality- of- life in these patients.
PrOSPErO registration number CRD42020169699.
IntrODuCtIOn
Pelvic ring fractures (PRFs) result from high- 
energy injuries and are associated with devas-
tating acute and chronic complications as 
severe and life- threatening haemorrhage or 
chronic pain and impaired ambulation.1–5 
The initial treatment of PRF is guided by 
the fracture morphology, pathophysiologic 
reaction of the organism to the trauma and 
concomitant injuries.6–9 After initial haemo-
dynamic stabilisation and fixation of the PRF, 
an interdisciplinary team- approach aims to 
improve long- term outcomes and to reduce 
complications.10 11 In male patients suffering 
PRF, erectile dysfunction (ED) is one of the 
main long- term complications. ED ranks 
among the adverse effects after PRF that 
severely impair the quality- of- life (QoL) in 
these patients, especially when urogenital 
damage is involved.12–14 The treatment of 
ED depends on the underlying pathogen-
esis and on patient- specific factors—it ranges 
from psychological behaviour therapy and 
pharmacological support until surgical inter-
ventions.15 The incidence of ED after PRF 
varies across the published literature due to 
a lack of epidemiologic studies investigating 
this subject, indicating a high number of 
unreported cases. It further remains unclear 
what the consequences of ED after PRF in 
the young male population is and whether 
patients with PRF benefit from early pharma-
cological penile rehabilitation therapy with 
phosphodiesterase-5- inhibitors (PDE-5- I). 
Therefore, this meta- analysis aims to answer 
the following questions: (a) Is the incidence 
of ED associated with the severity of PRF? and 
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rehabilitation after PRF with the help of PDE-5- I? We 
hypothesise that the rate of ED is associated with the 
increasing severity of PRFs and that pharmacological 
penile rehabilitation improves blood circulation in the 
pelvic organ region and therefore reduces the chances of 
persistent ED.
MEthODS
This study was conducted following the Preferred 
Reporting Items for Systematic Reviews and Meta- Analyses 
(PRISMA) guidelines.16 17 It was recorded on PROSPERO, 
the prospective register of systematic reviews.
Search strategy and definitions
A scientific librarian and information expert, specialised 
in medical research, conducted a systematic literature 
search of the Cochrane, EMBASE, MEDLINE, Scopus and 
Web of Science Library databases in January 2020. PRFs 
are classified following Young and Burgess,18 Tile19 or the 
Arbeitsgemeinschaft für Osteosynthesefragen/Ortho-
pedic Trauma Association classification.20 ED was evalu-
ated based on the 5- item International Index of Erectile 
Function (IIEF-5) questionnaire.21 22 Presence of ED was 
defined as a score between 5 and 21 (severe–mild ED) 
according to results on IIEF-5 questionnaires. Categori-
sation according to the achieved IIEF-5 score leads to the 
following subgrouping: ‘Severe’ (5–7 points), ‘moderate’ 
(8–11 points), ‘mild to moderate’ (12–16 points), ‘mild’ 
(17–21 points) and ‘no’ (22–25 points) ED.23 The term 
‘penile rehabilitation’ refers to the treatment of ED with 
PDE-5- I. Penile rehabilitation is a urological concept to 
enhance ED in patients after nerve- sparing radical pros-
tatectomy due to prostate cancer. The idea of this treat-
ment is to enhance blood circulation in the postoperative 
period (3–6 months) after the intervention to amelio-
rate neurovascular regeneration and to avoid cavernous 
fibrosis. Although penile rehabilitation has been subject 
to some debate, this concept might be also helpful in 
young male patients after trauma to the pelvis. PRFs 
frequently lead to damage in the neurovascular structures 
of the pelvis. As a consequence, male patients may experi-
ence ED and therefore a severely reduced QoL.
Inclusion/exclusion criteria
Inclusion criteria were original studies performed on 
humans assessing ED after PRF written in French, Spanish, 
Italian, German and English language. No specific time 
limits were used. To increase comparability, we only 
included articles that assessed ED based on IIEF-5 and 
classified the severity of PRF accordingly (see above). We 
included interventional cohort studies assessing the effect 
of PDE-5- I on ED after PRF with the reported change of 
the IIEF-5 scores prior and after PDE-5- I treatment as 
main outcome parameter. Articles assessing secondary 
ED after treatment of urethral injuries were excluded. 
Furthermore, articles without full- text availability were 
excluded. Case reports, case series, narrative reviews, 
expert opinions, editorials, book chapters, conference 
abstracts, letters, commentaries, correspondences, in 
vitro and animal experiments were completely excluded 
from the systematic review. The full search string is shown 
in the online supplemental file.
Data management
The export of de- duplicated publications from all sources 
were saved in an EndNote library. Two authors (FAS 
and SH) received the same library and independently 
screened and assorted all articles within the publicly avail-
able web- tool Rayyan.24
Study selection
According to the PRISMA flow diagram, steps of 
screening were performed as follows16: (1) title and 
abstract screening, (2) full- text screening, (3) extraction 
and storage of data and (4) qualitative and quantitative 
evidence synthesis. After title and abstract screening, full 
texts were obtained for formal inclusion or exclusion into 
our systematic review. Full text analysis was performed 
independently by two authors (FAS and SH). Discrep-
ancies were resolved by consensus or, if necessary, until 
consensus was reached. Studies that did not provide the 
type of PRF and the subsequent proportion of patients 
with ED, as well as no baseline scores of IIEF-5 ques-
tionnaires (before PDE-5- I therapy) for the evaluation 
of penile rehabilitation, were not included in the quan-
titative analysis. However, some of these studies were 
summarised in a narrative way.
Data extraction
The following data were extracted from published arti-
cles: (1) general study information: author, year, country 
and study design (ie, prospective or retrospective); (2) 
patient characteristics: sample size, age, type of pelvic 
injury (category) and follow- up time (months); (3) 
outcome: rate of patients with ED (proportion), mean 
or median IIEF-5 score (absolute values) either after 
trauma and follow- up or before and after treatment and 
IIEF-5 category (categorical values); (4) associated inju-
ries: urogenital injuries (proportion) or urethral injury 
(proportion), other injury sites (amount) and (5) treat-
ment: medication (type of PDE-5- I), dosage (mg) and 
treatment duration (months).
The data were extracted independently and in dupli-
cate by two authors (FAS and SH) on separate copies of 
an Excel spreadsheet. These were compared and discrep-
ancies were resolved by consensus.
risk of bias
Risk of bias assessment was conducted using the revised 
tool for the Quality Assessment on Diagnostic Accuracy 
Studies.25 Each study was assessed for risk of bias through 
four key domains: patient selection, usage of standardised 
IIEF-5 questionnaires, grouping into internationally 
accepted pelvic fracture classifications, and flow and 
timing. For each domain, the two authors (FAS and SH) 
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Figure 1 Preferred Reporting Items for Systematic Reviews 
and Meta- Analyses flow diagram of study selection.
risk of bias. Again, discrepancies were resolved through 
discussion or until consensus was reached.
Statistical analysis
Descriptive statistics on study level were reported as 
mean values and proportions. For evidence synthesis 
for continuous outcomes, mean values with SDs were 
used for pooling in a random effects model. If studies 
reported mean values with SEs, the SD was computed 
using the formula provided by the Cochrane collabora-
tion: SD=SE×√N.26 For studies which reported values as 
median with range or IQR, we estimated the mean and 
SD according to the formulas by Wan et al.27 To confirm 
the reliability of these estimations, we performed them in 
duplicate using the formulas by Luo et al,28 and compared 
the results of the two methods. Both methods have in 
general shown good reliability for these estimations, even 
in presence of deviation from the normal distribution.29 
Evidence synthesis for binary outcomes was done by 
dividing reported numbers of patients with the condition 
over total number of patients in each study, and these 
proportions were used for pooling in a random effects 
logistic regression model. The random effects model 
computes exact 95% CIs based on the binomial distribu-
tion for the overall effect.
Results were presented as forest plots of mean changes 
of IIEF-5 questionnaires before and after penile rehabili-
tation, or proportions of patients with ED including 95% 
CI. In one forest plot, studies were ordered by subtypes of 
PRFs. To quantify heterogeneity, the Q- test (total between- 
study variance), I2- statistic (proportion of total variation) 
and H2- statistic (ratio of total amount of variability and 
amount of sampling variance) was calculated for all meta- 
analyses. All statistical analyses were performed using R 
(V.3.4.2).30
Patient and public involvement
No patient involved.
rESultS
Study selection and characteristics
According to the systematic literature research and after 
removal of duplicates, 617 articles were found. The initial 
screening process for title and abstract excluded 556 arti-
cles. The full- text analysis of the remaining 61 articles led 
to the exclusion of further 54 articles. We included four 
articles assessing the incidence of ED after PRF based on 
IIEF-5 and three articles investigating the treatment effect 
of PDE-5- I on ED after PRF (figure 1). Articles included 
for qualitative and quantitative analysis were published 
between the years 2000 and 2019 and were all retrospec-
tive cohort studies (table 1).
Incidence of ED after PrF
The analysis for the incidence of ED after PRF included 
181 male patients with mean age 42 years. Of these, 65 
patients (35.9%) reported ED based on IIEF-5 score of 
≤21 points. The mean follow- up was 24.01±10.91 months. 
The overall mean IIEF-5 score was 20.01±2.01 points. The 
rate of ED after anterior–posterior compression (APC) 
fracture or type A fractures was 29.27%. The rate of ED 
after lateral compression (LC) or type B PRF was 17.86%. 
After vertical shear (VS) or type C PRF 48% of patients 
suffered from ED. PRF with associated pelvic fracture 
urethral injury (PFUI) led to a higher percentage of ED 
than PRF without PFUI (58.6% vs 38.1%). Pooling the 
proportions with the random- effects model resulted 
in 37% of patients with ED after suffering any form of 
PRF (result on probability scale pr=0.37, 95% CI: 0.26 to 
0.50). As a measure of heterogeneity, the percentage of 
variability (I2) was moderate with 44.2% (p value=0.021).
Elevated probabilities for the development of ED 
after PRF was described in Tile fractures types B and C 
(pr=0.62; 95% CI: 0.28 to 0.87 and pr=0.80; 95% CI: 0.31 
to 0.97, respectively) as well as with injuries associated 
with PFUI (pr=0.59; 95% CI: 0.40 to 0.75). Duramaz et 
al reported higher proportions of ED in patients with 
APC and VS (pr=0.42; 95% CI: 0.18 to 0.69 and pr=0.40; 
95% CI: 0.21 to 0.62, respectively) compared with LC 
fractures (pr=0.02; 95% CI: 0.00 to 0.29) according to 
Young and Burgess. Fanjalalaina Ralahy et al reported the 
highest proportion of ED with 80% of patients affected 
after PRF Tile C (pr=0.80; 95% CI: 0.31 to 0.97). The 
lowest proportion of ED was demonstrated by Duramaz 
et al in LC fractures with 0% of patients developing ED 
after a follow- up of 27 months (pr=0.02; 95% CI: 0.00 
to 0.29). Furthermore, the type A fractures presented 
by Fanjalalaina Ralahy et al and the overall chances to 
develop ED in a combined group of A, B and C fractures 
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Table 1 Included articles
Author Year Country Study design N
Mean age, 
years (range) Inclusion Main result
Nieto 2017 Mexico Retrospective 
cohort study
8 32.5 (26–56) Treatment 
effect PDE-
5- I
Nearly all patients (87.5%) 
had a positive effect on IIEF-
5 questionnaires after penile 
rehabilitation treatment with 
tadalafil 5 mg for 3 months.
Peng 2014 China Retrospective 
cohort study
31 33.1 (26–46) Treatment 
effect PDE-
5- I
More than half of the patients 
(54.8%) reported a successful 
penile rehabilitation with better 
IIEF-5 score after 3 months 
treatment with sildenafil 50 mg.
Peng 2015 China NFS 28 34 (22–49) Treatment 
effect PDE-
5- I
Almost two- thirds of the 
patients (61.5%) witnessed a 
positive effect on IIEF-5 scores 
after penile rehabilitation with 
sildenafil 50 mg for 3 months.
Chung 2018 USA Retrospective 
cohort study
29 52 (18 –>70) Incidence 
of ED after 
PRF
ED was reported in 47.5% of all 
patients following PRF according 
to IIEF-5 scores.
Duramaz 2019 Turkey Retrospective 
cohort study
52 35 (19–50) Incidence 
of ED after 
PRF
Vertical shear injuries were the 
most common type of PRF 
in patients who suffered ED 
according to IIEF-5 scores.
Fanjalalaina 
Ralahy
2019 Madagascar Retrospective 
cohort study
42 39.6 (18–>66) Incidence 
of ED after 
PRF
One in three patients (33.3%) 
suffered ED following PRF 
according to IIEF-5 scores.
Malavaud 2000 France Retrospective 
cohort study
37 37.8 (16–76) Incidence 
of ED after 
PRF
Nearly one in three patients 
(29.7%) reported ED following 
PRF according to IIEF-5 scores.
ED, erectile dysfunction; IIEF-5, International Index of Erectile Function-5; n, number of patients; NFS, not further specified; PDE-5- I, 
phosphodiesterase-5 inhibitor; PRF, pelvic ring fracture.
Figure 2 Weighted forest plot displaying the proportion of patients developing ED according to PRF classification. ABC, Tile A, 
B and C fractures; APC, anterior–posterior compression; ED, erectile dysfunction; LC, lateral compression; PFUI, pelvic fracture 
urethral injury; PRF, pelvic ring fracture; VS, vertical shear according to Young and Burgess.
studies of comparison (pr=0.24; 95% CI: 0.12 to 0.43 and 
OR=0.30; 95% CI: 0.17 to 0.46, respectively). For overall 
results, please see forest plot in figure 2.
Effect of penile rehabilitation in patients with PrF
Three studies with cumulative 67 patients investigated 
the effect of penile rehabilitation using PDE-5- I for the 
treatment of ED after PRF with concomitant PFUI. The 
mean age of patients across studies was 33 years. Either 
sildenafil (50 mg) or tadalafil (5 mg) were used for a 
treatment duration of 3 months. The mean IIEF- score 
after PRF and before treatment was 6.69±1.16 points 
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Figure 3 Forest plot displaying the treatment effect as mean change score between IIEF-5 scores before and after penile 
rehabilitation treatment with PDE-5- I. IIEF-5, International Index of Erectile Function-5; PDE-5- I, phosphodiesterase-5- inhibitors; 
PFUI, pelvic fracture urethral injury.
Figure 4 Domains in risk of bias of all included studies 
according to QUADAS-2 tool. (A) Traffic light plot and (B) 
weighted summary plot. IIEF-5, International Index of Erectile 
Function-5; QUADAS, Quality Assessment on Diagnostic 
Accuracy Studies.
There was strong evidence that the IIEF-5 score in patients 
after penile rehabilitation therapy was higher than the 
IIEF-5 score before treatment (change score (CS)=6.5 
points increase, 95% CI: 2.54 to 10.46, p value=0.0013). 
The largest difference in IIEF-5 scores before and after 
3 months of tadalafil treatment (5 mg) was reported by 
Nieto et al (CS=10.75, 95% CI: 8.04 to 13.46). Peng et al 
published in 2014 the smallest effect of penile rehabilita-
tion therapy after 3 months of sildenafil (50 mg) with a 
statistically higher IIEF score, comparing before and after 
treatment (CS=4.00, 95% CI: 3.01 to 4.99). A consider-
able heterogeneity was observed between the studies in 
this meta- analysis, justifying the use of a random- effects 
model (I2=93%, p<0.0001). For summarised results, 
please see forest plot in figure 3.
Study quality
The assessment of study quality is depicted in figure 4. 
The overall quality of the included studies was low due to 
a rather high risk of bias. We found selection bias to be a 
concern for more than half of the included studies. This 
was due to studies not following consecutive recruitment, 
no or partial definition of inclusion and exclusion criteria 
as well as time and/or place of recruitment. Either no 
or only sparse information was available on the different 
types of fractures that were subdivided into groups of 
internationally accepted classifications. Finally yet impor-
tantly, flow and timing of the study was associated with a 
high risk of bias in almost all cases, except for Fanjalalaina 
Ralahy et al.31
DISCuSSIOn
PRF resulting from high- energy trauma is associated with 
increased mortality,3 impaired QoL32–34 and concomitant 
injuries of pelvic organs.35 Among other adverse effects, 
ED is an underestimated functional complication in male 
patients after PRF.36 The aim of this article was to assess 
the rate of ED after PRF and the effect of pharmacolog-
ical penile rehabilitation with PDE-5- I on assessed, stan-
dardised IIEF-5 questionnaires. The following two points 
can be regarded as quintessence of this systematic review 
and the underlying meta- analysis: (a) male patients after 
PRF have a significant risk (37%) of developing any form 
of ED according to IIEF-5 scores, independent of injury 
severity and (b) pharmacological penile rehabilitation 
with PDE-5- I improves the individual IIEF-5 score by 6.5 
points after a consecutive treatment of 3 months following 
injury in a male cohort with PRF and PFUI.
rate of ED after PrF
The rate of ED after PRF is subject of substantial research 
activities. In one of the first published articles dealing 
with this topic in 1975, King37 reviewed 90 patients and 
noted an incidence of 5%–42% of ED after pelvic trauma, 
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with concomitant urethral injury. In 2007, Metze et al38 
investigated the rate of ED after PRF in 77 men using a 
long version of the IIEF questionnaire for evaluation. They 
reported 61% of patients with limitations in sexual func-
tion, 19% with persistent impairment and an increased 
risk of persistence with associated posterior ring disrup-
tions (Tile fracture C). The IIEF is known to be a simple 
questionnaire that meets established criteria, is consis-
tent and reliable regarding test–retest reproducibility. Its 
validity to evaluate improvement of EF after ED treatment 
is further justified.39 Another study noted the rate of 
moderate and severe ED based on the IIEF-5 score to be 
46.1%, increasing in line with the complexity of the frac-
tures (Tile fractures B and C), whereas mild and moderate 
forms of ED were present in 53.9% of patients affected 
from type A fractures.40 A recent publication concluded, 
similar to our observed results, that APC and VS fractures 
according to Young and Burgess are more associated with 
ED in men and sexual dysfunction in both sexes, than 
LC fractures.41 In a review article from Harwood et al,42 
the rate of ED after pelvic fractures without PFUI ranges 
from 5% to 24% and from 9% to 72% with PFUI. They 
discussed the broad variance of assessment tools for ED 
as well as concomitant injuries as relevant reasons for the 
broad variability of the gathered data.42 Several studies 
investigated the pathogenesis of ED following pelvic frac-
tures, identifying vasculogenic,43–47 neurogenic43–46 48 and 
psychogenic44 47 etiologies. One of the most commonly 
investigated risk factor for developing ED following PRF 
is the presence and severity of urethral injuries as collat-
eral damage.13 46 49 50 However, the management and the 
relevance of early versus delayed surgical or conservative 
treatment approaches after PFUI is still controversially 
discussed.51–54 Excluding PFUI, this study concludes an 
incidence of ED based on standardised IIEF-5 question-
naires of 41.5% ranging from 29.7% to 71.4%, whereas 
the broad variance of incidence is mostly depending on 
injury severity. According to our meta- analysis, there is a 
visible trend for an increased rate of ED among higher 
classifications of PRF injuries. The severity of PRFs are 
associated with concomitant injuries such as vascular,55 
nerve56 as well as abdominal and urogenital organ 
damage.35 Wright et al57 identified that patients with 
sacroiliac fractures to have at least a four times higher risk 
for sexual and excretory dysfunction. Furthermore, it has 
been demonstrated, that patients suffer from a decreased 
QoL after more severe forms of PRFs.33 58 59 All these risk 
factors, including higher trauma energy, are therefore 
associated with the development of persistent ED.42 60
treatment of ED after PrF
Strategies to treat ED as a consequence of PRF include 
pharmacological, mechanical and invasive treatment 
approaches. Initial attempts in Italy used papaverine and 
prostaglandin E1 as vasodilatative, intracavernous injec-
tions.61 In 2004, Shenfeld et al62 treated patients with 
ED after PFUI with 100 mg oral sildenafil (PDE-5- I) on 
demand for 3–6 months. Forty- seven percent responded 
favourably to treatment, of which one- third reported 
resumption of normal spontaneous erections during the 
follow- up of 18 months. Oral PDE-5- I therapy is regarded 
as standard of care and serves as initial reference treat-
ment in men suffering from ED.63–65 Both sildenafil and 
tadalafil are commonly used representatives of PDE5- I in 
the treatment of ED with comparable safety and efficacy.66 
The management of concomitant injuries following PRF 
includes the early diagnostics and exclusion or treat-
ment of organic damages to prevent or reduce the risk of 
ED.13 14 42 According to the results of our meta- analysis, the 
treatment with PDE-5- I increases the IIEF-5 score by 6.5 
points in patients with ED after PRF with urethral injury. 
However, it remains unclear whether it also supports the 
permanent recovery of spontaneous erectile function. 
Similarly, the data for the efficacy of penile rehabilita-
tion after radical prostatectomy are still controversially 
discussed.67 68 The effect seems to be ameliorated with 
a regular treatment regime compared with on- demand 
use of PDE-5- I in patients with ED after radical prostatec-
tomy.69 The current limited evidence demonstrates, that 
daily oral intake of PDE-5- I seems to have also a relevant 
positive effect on ED in 55%–88% of patients after PRF 
with or without associated PFUI.70–73 Furthermore, the 
efficacy of pharmacological therapy can also be supported 
with mechanical aids, such as the use of vacuum erection 
devices or low- intensity shock- wave therapy. Both have 
shown to ameliorate IIEF-5 score and erection quality 
when used in combination with PDE-5- I, compared with 
stand- alone treatment.74–76 Finally, the implantation of 
penile prosthesis or revascularisation surgery are both 
regarded as last resort options in ED treatment of patients 
after perineal or pelvic surgery or trauma.77
limitations and strengths
This systematic review and its meta- analysis have some 
limitations. Despite the strict definition of PRF and ED, 
all of the included studies present an inevitable variability 
due to their heterogeneous methodology and study 
populations coming from different centres worldwide. 
Therefore and due to the lack of standardisation, a broad 
variety of PRF classifications and different definitions 
as well as questionnaires for the evaluation of ED were 
used. Furthermore, all of the included studies provide 
a considerable risk of bias (figure 4). In addition, there 
are general limitations to systematic reviews regarding 
the search algorithm and the potential to miss relevant 
articles (selection bias, publication bias, language bias, 
time lag bias, etc). However, all of the included studies 
showed consistent and overall comparable outcomes, 
which implicates a representative cohort with reliable and 
repeatable results included in this analysis.
COnCluSIOn
Patients who suffer from PRF have an increased risk of 
developing ED, regardless of the classification severity 
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rehabilitation with the pharmacological help of PDE-5- I 
on a daily basis and a treatment duration of at least 3 
months may relevantly reduce ED after PRF and there-
fore ameliorate QoL in these patients.
twitter Florian A Schmid @Schmid_FA
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